52
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid

, , , , , & show all
Pages 555-560 | Published online: 10 Aug 2011

References

  • LindRArslanGEriksenHRA Subjective health complaints and modern health worries in patients with subjective food hypersensitivityDig Dis Sci2005501245125116047467
  • ArslanGLindROlafssonSFlorvaagBerstadAQuality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia IndexDig Dis Sci20044968068715185878
  • LillestølKBerstadALindRFlorvaagELiedGATangenTAnxiety and depression in patients with self-reported food hypersensitivityGen Hosp Psychiatry201032424820114127
  • LindRLiedGALillestølKValeurJBerstadADo psychological factors predict symptom severity in patients with subjective food hypersensitivity?Scand J Gastroenterol20104583584320433401
  • LiXChenHLuHThe study on the role of inflammatory cells and mediators in post-infectious functional dyspepsiaScand J Gastroenterol20104557358120163288
  • DunlopSPJenkinsDNealKSpillerRRelative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBSGastroenterology20031251651165914724817
  • ValeurJMildeAMHelleKBBerstadALow serum chromogranin A in patients with self-reported food hypersensitivityScand J Gastroenterol2008431403140418654936
  • HelleKBChromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine systemResults Probl Cell Differ201050214420217490
  • LundgrenO5-Hydroxytryptamine, enterotoxins, and intestinal fluid secretionGastroenterology1998115100910129786724
  • TurvillJLConnorPFarthingMJThe inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the ratBr J Pharmacol20001301031103610882387
  • SangerGJNew antiemetic drugsCan J Physiol Pharmacol1990683143242178755
  • McCormickDCarcinoid tumors and syndromeGastroenterol Nurs20022510511112055378
  • AtkinsonWLockhartSWhorwellPJKeevilBHoughtonLAAltered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndromeGastroenterology2006130344316401466
  • DunlopSPColemanNSBlackshawEAbnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndromeClin Gastroenterol Hepatol2005334935715822040
  • HoughtonLAAtkinsonWWhitakerRPWhorwellPJRimmerMJIncreased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndromeGut20035266367012692050
  • WheatcroftJWakelinDSmithAMahoneyCRMaweGSpillerREnterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunctionNeurogastroenetrol Motil200517863870
  • WangSHDongLLuoJYDecreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndromeWorld J Gastroenterol2007136041604718023097
  • GregersenKFrøylandLBerstadAAraujoPDirect determination of serotonin in gut lavage fluid by liquid chromatographic ion trap tandem mass spectrometryTalanta20087546647218371908
  • NilssonOAhlmanHGeffardMDahlströmAEricsonLEBipolarity of duodenal enterochromaffin cells in the ratCell Tissue Res198724849543552241
  • AhlmanHBhargavaHNDahlströmALarssonINewsonBPetterssonGOn the presence of serotonin in the gut lumen and possible release mechanismsActa Physiol Scand19811122632696974954
  • ForsbergEJMillerRJCholinergic agonists induce vectorial release of serotonin from duodenal enterochromaffin cellsScience19822173553567089569
  • BerstadAArslanGFolvikGRelationship between intestinal permeability and calprotectin concentration in gut lavage fluidScand J Gastroenterol20001646910672837
  • ArslanGKahrsGELindRFrøylandLFlorvaagEBerstadAPatients with subjective food hypersensitivity: the value of analyzing intestinal permeability and inflammation markers in gut lavage fluidDigestion200470263515297775
  • ThompsonWGLongstrethGFDrossmanDAHeatonKWIrvineEJMuller-LissnerSAFunctional bowel disorders and functional abdominal painGut199945II43II4710457044
  • LillestølKHelgelandLILiedAGIndications of ‘atopic bowel’ in patients with self-reported food hypersensitivityAliment Pharmacol Ther2010311112112220163379
  • GustafssonBIBakkeITømmeråsKWaldumHLA new method for visualization of gut mucosal cells, describing the enterochromaffin cell in the rat gastrointestinal tractScand J Gastroenterol20064139039516635905
  • GershonMDThe serotonin signaling system: from basic understanding to drug development for functional GI disordersGastroenterology200713239741417241888
  • KimHSLimJHParkHLeeSIIncreased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection – an observation in a small case control studyYonsei Med J201051455120046513
  • CoatesMDMahoneyCRLindenDRMolecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndromeGastroenterology20041261657166415188158
  • BishopAEPietrolettiRTaatCWBrummelkampWHPolakJMIncreased populations of endocrine cells in Crohn’s ileitisVirchows Arch A Pathol Anat Histopathol19874103913963103321
  • El-SalhyMDanielssonAStenlingRGrimeliusLColonic endocrine cells in inflammatory bowel diseaseJ Intern Med19972424134199408072
  • WangHSteedsJMotomuraYCD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infectionGut20075694995717303597
  • MotomuraYGhiaJEWangHEnterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environmentsGut20085747548118198200
  • Cloëz-TayaraniIChangeuxJPNicotine and serotonin in immune regulation and inflammatory processes: a perspectiveJ Leukoc Biol20078159960617108054
  • LadabaumUSafety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implicationsAliment Pharmacol Ther2003171021103012694084
  • SidhuRMcAlindonMELeedsJSSkillingJSandersDSThe role of serum chromogranin a in diarrhoea predominant irritable bowel syndromeJ Gastrointestin Liver Dis200918232619337629
  • ShooshtarizadehPZhangDChichJFThe antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunityRegul Pept201016510211019932135
  • KhanWIGhiaJEGut hormones: emerging role in immune activation and inflammationClin Exp Immunol2010161192720408856
  • UribeAAlamMJohanssonOMidtvedtTTheodorssonEMicroflora modulates endocrine cells in the gastrointestinal mucosa of the ratGastroenterology1994107125912697926490
  • ValeurJMorkenMHNorinEMidtvedtTBerstadAIntestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?Clin Exp Gastroenterol20103657021694848
  • DlugoszATörnblomHMohammadianGChlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndromeBMJ Gastroenterol20101019
  • El-SalhyMLomholt-BeckBHauskenTChromogranin A as a possible tool in the diagnosis of irritable bowel syndromeScand J Gastroenterol2010451435143920602602